일본의 디지털 병리학 시장 보고서 : 제품, 유형, 제공 모델, 용도, 최종 사용자, 지역별(2024-2032년)

Japan digital pathology market size reached US$ 36.11 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 118.34 Million by 2032, exhibiting a growth rate (CAGR) of 13.50% during 2024-2032. The widespread investments by key players in the healthcare technologies are primarily driving the market growth.

Digital pathology is a cutting-edge medical technology that revolutionizes the traditional practice of examining tissue samples for disease diagnosis. Instead of using conventional glass slides, digital pathology involves the digitization of tissue samples into high-resolution images. These digital images are then stored, analyzed, and shared electronically, enabling pathologists and medical professionals to collaborate and make diagnoses remotely. Digital pathology offers numerous advantages, including improved accuracy, speed, and efficiency in diagnosing diseases such as cancer. It also facilitates the integration of artificial intelligence and machine learning algorithms, which can assist in automating certain aspects of image analysis and enhancing diagnostic precision. Additionally, digital pathology allows for the creation of extensive digital archives, enabling researchers to access and study a vast repository of medical data for various purposes, including medical research, education, and quality assurance in healthcare settings.

Japan Digital Pathology Market Trends:

The digital pathology market in Japan is witnessing significant growth and transformation within the country's healthcare landscape. Japan, known for its technological advancements, is embracing digital pathology as a powerful tool to enhance disease diagnosis and patient care. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses. With a growing aging population, the demand for precise and timely pathology services is increasing, making digital pathology an invaluable asset in managing healthcare needs efficiently. Additionally, the integration of artificial intelligence and machine learning into digital pathology systems is enhancing diagnostic capabilities further. These innovations not only improve diagnostic accuracy but also help address the challenges posed by a shortage of pathologists in the country. As Japan continues to invest in healthcare technologies, the digital pathology market is poised for continued growth and innovation to meet the evolving demands of the healthcare sector.

Japan Digital Pathology Market Segmentation:

Product Insights:

• Scanners
• Software
• Storage Systems
• Communication Systems

Type Insights:

• Human Pathology
• Veterinary Pathology

Delivery Model Insights:

• On-premises
• Hosted

Application Insights:

• Training and Education
• Consulting Services
• Intraoperative Consultation
• Routine Diagnostic Consultation Services
• Others

End User Insights:

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan digital pathology market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan digital pathology market?
• What is the breakup of the Japan digital pathology market on the basis of product?
• What is the breakup of the Japan digital pathology market on the basis of type?
• What is the breakup of the Japan digital pathology market on the basis of delivery model?
• What is the breakup of the Japan digital pathology market on the basis of application?
• What is the breakup of the Japan digital pathology market on the basis of end user?
• What are the various stages in the value chain of the Japan digital pathology market?
• What are the key driving factors and challenges in the Japan digital pathology?
• What is the structure of the Japan digital pathology market and who are the key players?
• What is the degree of competition in the Japan digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Pathology Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Digital Pathology Market Landscape

• 5.1 Historical and Current Market Trends (2018-2023)
• 5.2 Market Forecast (2024-2032)

6 Japan Digital Pathology Market - Breakup by Product

• 6.1 Scanners
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2018-2023)
  • 6.1.3 Market Forecast (2024-2032)
• 6.2 Software
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2018-2023)
  • 6.2.3 Market Forecast (2024-2032)
• 6.3 Storage Systems
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2018-2023)
  • 6.3.3 Market Forecast (2024-2032)
• 6.4 Communication Systems
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2018-2023)
  • 6.4.3 Market Forecast (2024-2032)

7 Japan Digital Pathology Market - Breakup by Type

• 7.1 Human Pathology
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2018-2023)
  • 7.1.3 Market Forecast (2024-2032)
• 7.2 Veterinary Pathology
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2018-2023)
  • 7.2.3 Market Forecast (2024-2032)

8 Japan Digital Pathology Market - Breakup by Delivery Model

• 8.1 On-premises
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2018-2023)
  • 8.1.3 Market Forecast (2024-2032)
• 8.2 Hosted
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2018-2023)
  • 8.2.3 Market Forecast (2024-2032)

9 Japan Digital Pathology Market - Breakup by Application

• 9.1 Training and Education
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2018-2023)
  • 9.1.3 Market Forecast (2024-2032)
• 9.2 Consulting Services
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2018-2023)
  • 9.2.3 Market Forecast (2024-2032)
• 9.3 Intraoperative Consultation
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2018-2023)
  • 9.3.3 Market Forecast (2024-2032)
• 9.4 Routine Diagnostic Consultation Services
  • 9.4.1 Overview
  • 9.4.2 Historical and Current Market Trends (2018-2023)
  • 9.4.3 Market Forecast (2024-2032)
• 9.5 Others
  • 9.5.1 Historical and Current Market Trends (2018-2023)
  • 9.5.2 Market Forecast (2024-2032)

10 Japan Digital Pathology Market - Breakup by End User

• 10.1 Pharmaceutical and Biotechnology Companies
  • 10.1.1 Overview
  • 10.1.2 Historical and Current Market Trends (2018-2023)
  • 10.1.3 Market Forecast (2024-2032)
• 10.2 Hospitals and Reference Laboratories
  • 10.2.1 Overview
  • 10.2.2 Historical and Current Market Trends (2018-2023)
  • 10.2.3 Market Forecast (2024-2032)
• 10.3 Academic and Research Institutes
  • 10.3.1 Overview
  • 10.3.2 Historical and Current Market Trends (2018-2023)
  • 10.3.3 Market Forecast (2024-2032)

11 Japan Digital Pathology Market - Competitive Landscape

• 11.1 Overview
• 11.2 Market Structure
• 11.3 Market Player Positioning
• 11.4 Top Winning Strategies
• 11.5 Competitive Dashboard
• 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

• 12.1 Company A
  • 12.1.1 Business Overview
  • 12.1.2 Product Portfolio
  • 12.1.3 Business Strategies
  • 12.1.4 SWOT Analysis
  • 12.1.5 Major News and Events
• 12.2 Company B
  • 12.2.1 Business Overview
  • 12.2.2 Product Portfolio
  • 12.2.3 Business Strategies
  • 12.2.4 SWOT Analysis
  • 12.2.5 Major News and Events
• 12.3 Company C
  • 12.3.1 Business Overview
  • 12.3.2 Product Portfolio
  • 12.3.3 Business Strategies
  • 12.3.4 SWOT Analysis
  • 12.3.5 Major News and Events
• 12.4 Company D
  • 12.4.1 Business Overview
  • 12.4.2 Product Portfolio
  • 12.4.3 Business Strategies
  • 12.4.4 SWOT Analysis
  • 12.4.5 Major News and Events
• 12.5 Company E
  • 12.5.1 Business Overview
  • 12.5.2 Product Portfolio
  • 12.5.3 Business Strategies
  • 12.5.4 SWOT Analysis
  • 12.5.5 Major News and Events

13 Japan Digital Pathology Market - Industry Analysis

• 13.1 Drivers, Restraints, and Opportunities
  • 13.1.1 Overview
  • 13.1.2 Drivers
  • 13.1.3 Restraints
  • 13.1.4 Opportunities
• 13.2 Porters Five Forces Analysis
  • 13.2.1 Overview
  • 13.2.2 Bargaining Power of Buyers
  • 13.2.3 Bargaining Power of Suppliers
  • 13.2.4 Degree of Competition
  • 13.2.5 Threat of New Entrants
  • 13.2.6 Threat of Substitutes
• 13.3 Value Chain Analysis

14 Appendix